Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
3.120
+0.060 (1.96%)
At close: Nov 18, 2025, 4:00 PM EST
3.050
-0.070 (-2.24%)
After-hours: Nov 18, 2025, 6:10 PM EST
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $118.75 million as of November 18, 2025. Its market cap has decreased by -53.72% in one year.
Market Cap
118.75M
Enterprise Value
18.82M
1-Year Change
-53.72%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $118.75M, a decrease of -75.67%. That is a compound annual growth rate of -27.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 116.47M | -57.63% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |